We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » WHO PULLS RANBAXY'S GENERIC COMBO AIDS DRUG FROM LIST
WHO PULLS RANBAXY'S GENERIC COMBO AIDS DRUG FROM LIST
August 10, 2004
Three of Ranbaxy Laboratories’ generic fixed-dose combination (FDC) AIDS drugs have been removed from the World Health Organization’s (WHO’s) list of recommended medicines based on concerns the products may not be bioequivalent to their brand counterparts.